Plain-English translation of NCT07031531 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a smartphone app called SMART-CHD that helps young people (ages 18–45) who have had early heart disease manage their condition better after leaving the hospital. The app uses artificial intelligence to track your health habits, monitor vital signs through wearable sensors, and send you personalized reminders about medications, diet, exercise, and other heart-healthy behaviors. Researchers want to see if using this technology reduces the chance of future heart attacks, strokes, or other serious events compared to receiving standard discharge instructions alone.
Young people with early heart disease often have poor outcomes after leaving the hospital because it's hard to stay on top of medications, lifestyle changes, and follow-up care. This study exists to see if a high-tech, personalized app can make it easier to manage these conditions and prevent serious complications.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to either use the SMART-CHD app or receive standard discharge instructions. If you're in the app group, you'll download the app, wear small sensors to track your blood pressure and heart rate, answer health questions in the app regularly, and receive automated reminders and support through a dedicated chat group for 12 months. You'll also have access to a care coordinator who can help you. Either way, the study will follow you for 12 months to see how well you're doing and whether you have any heart-related complications.
AI-generated summary from trial data · Jun 22, 2026 · Not medical advice
China